Security Snapshot

GENMAB A/S - Common Stock Institutional Ownership

CUSIP: K3967W102

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
64,539,527
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • K3967W102 - GENMAB A/S - Common Stock is tracked under CUSIP K3967W102.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
  • SEC-reported value moved from $4,477,269 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

K3967W102

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
K3967W102
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 5.6% 3,707,346 BlackRock, Inc. 31 Mar 2025
ORBIS INVESTMENT MANAGEMENT LTD 5.5% -16% 3,549,674 -16% ORBIS INVESTMENT MANAGEMENT LTD 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
45
Latest
n/a
Rows shown
1-25 of 45
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$4,477,269 0
2025 Q2 216,712 $4,477,269 +$4,477,269 $20.66 1
2024 Q4 0 $0 -$208,601 0
2024 Q3 862 $208,601 -$3,947,931 $242.00 1
2024 Q2 17,176 $4,306,092 -$1,113,410 $250.70 1
2024 Q1 20,842 $6,578,354 -$821,798 $1195.30 2
2023 Q4 21,876 $7,698,530 -$81,393 $1237.09 2
2023 Q3 22,131 $8,709,733 -$106,687 $1431.81 2
2023 Q2 22,431 $9,341,968 +$1,000,149 $1479.10 2
2023 Q1 22,057 $8,311,705 -$149,311 $376.83 1
2022 Q4 22,840 $10,648,957 +$1,112,352 $423.37 3
2022 Q3 22,526 $7,310,000 -$109,139 $326.31 2
2022 Q2 22,862 $7,404,000 -$556,405 $328.12 3
2022 Q1 24,581 $9,016,000 -$8,838 $350.07 2
2021 Q4 24,604 $9,609,000 +$464,359 $390.55 1
2021 Q3 23,415 $10,241,000 -$108,468 $437.37 1
2021 Q2 23,663 $9,683,000 +$10,230 $409.20 1
2021 Q1 23,638 $7,773,000 +$115,092 $328.83 1
2020 Q4 23,288 $9,746,000 -$39,757 $418.50 1
2020 Q3 23,383 $8,468,000 -$103,935 $362.14 1
2020 Q2 23,670 $7,922,000 -$41,836 $334.69 1
2020 Q1 23,795 $4,843,000 -$1,410,464 $203.53 1
2019 Q4 30,725 $6,783,000 -$195,377 $220.76 1
2019 Q3 31,610 $6,417,000 $203.01 1
2019 Q2 45,609 $8,387,000 -$777,667 $183.89 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .